Things to Come | GenomeWeb

Things to Come

The next few years may see a number of changes to medicine, but Francis Collins, the director of the US National Institutes of Health, is most excited about the prospect of people being able to have their genomes sequenced at a reasonable cost to inform and tailor their medical care, as he tells USA Today's Brian Gallagher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?